L3VLUP
ProSign in

IONS in the 13F filings

Ionis Pharmaceuticals Inc · CUSIP 462222100

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 31 Oct 2024
Managers listing it
16
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 14 listed it in both
Shares listed
53,238,688
combined, among listed positions
Reported value
$2.1bn
combined, at the quarter end

Among the 94 comparable managers: 11 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing IONS in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

16 of 16 holders

ActionFiling
Fidelity (FMR LLC)22,479,529$901m0.05%Added+584,7235 Nov 2026 (the filing on sec.gov)
Wellington Management Group LLP8,735,787$350m0.06%Added+2,166,97914 Nov 2024 (the filing on sec.gov)
Capital World Investors7,828,372$314munder 0.1%Added+5,576,28313 Nov 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc4,210,172$169munder 0.1%Added+275,86114 Nov 2024 (the filing on sec.gov)
Artisan Partners LP2,240,455$90m0.13%Added+569,41912 Nov 2024 (the filing on sec.gov)
Marshall Wace LLP1,920,464$77m0.09%Addedn.a.14 Nov 2024 (the filing on sec.gov)
ARK Investment Management LLC1,384,269$55m0.51%Added+23,24431 Oct 2024 (the filing on sec.gov)
Two Sigma Advisers LP1,332,411$53m0.13%Added+45,30014 Nov 2024 (the filing on sec.gov)
Two Sigma Investments LP919,077$37m0.08%Trimmed-109,06514 Nov 2024 (the filing on sec.gov)
Hudson Bay Capital Management LP766,900$31m0.12%Added+400,90013 Nov 2024 (the filing on sec.gov)
Man Group PLC596,263$24m0.06%Trimmed-37,14614 Nov 2024 (the filing on sec.gov)
Voloridge Investment Management LLC380,641$15m0.06%Newnew14 Nov 2024 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC362,888$15m0.10%Trimmed-360,73014 Nov 2024 (the filing on sec.gov)
Baillie Gifford & Co39,581$1.6munder 0.1%Trimmed-220,6735 Nov 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP28,479$1.1munder 0.1%Added+6,63214 Nov 2024 (the filing on sec.gov)
PDT Partners LLC13,400$537kunder 0.1%Trimmed-3014 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (2)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
16 in Q3 2024 to 13 in Q2 2026

Tracked managers listing it, at least.

0510152020162017201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
IONS by quarter
QuarterHoldersReported valueBuyersSellers
Q4 201514$1.8bnn.a.n.a.
Q1 20167$1.1bnn.a.n.a.
Q2 20163$667mn.a.n.a.
Q3 20164$1.1bnn.a.n.a.
Q4 20167$1.6bnn.a.n.a.
Q1 20175$1.4bnn.a.n.a.
Q2 20176$1.9bnn.a.n.a.
Q3 20176$1.9bnn.a.n.a.
Q4 20177$1.9bnn.a.n.a.
Q1 20187$1.6bnn.a.n.a.
Q2 20186$1.6bnn.a.n.a.
Q3 20188$2.1bnn.a.n.a.
Q4 201811$2.1bnn.a.n.a.
Q1 201914$3.5bnn.a.n.a.
Q2 201911$2.8bnn.a.n.a.
Q3 201910$2.6bnn.a.n.a.
Q4 201910$2.5bnn.a.n.a.
Q1 202014$2.1bnn.a.n.a.
Q2 202012$2.6bnn.a.n.a.
Q3 202015$2.1bnn.a.n.a.
Q4 202014$2.5bnn.a.n.a.
Q1 20219$1.9bnn.a.n.a.
Q2 202110$1.8bnn.a.n.a.
Q3 20218$1.4bnn.a.n.a.
Q4 20219$1.3bnn.a.n.a.
Q1 20229$1.6bnn.a.n.a.
Q2 202212$1.6bnn.a.n.a.
Q3 202211$1.5bnn.a.n.a.
Q4 20229$1.2bnn.a.n.a.
Q1 20237$1.0bnn.a.n.a.
Q2 202310$1.3bnn.a.n.a.
Q3 202312$1.4bnn.a.n.a.
Q4 202314$1.9bn104
Q1 202415$1.7bn95
Q2 202417$2.1bn125
Q3 202416$2.1bn117
Q4 202411$1.7bn75
Q1 202510$1.5bn73
Q2 202513$2.1bn85
Q3 202518$3.6bn98
Q4 202515$4.9bn1520
Q1 202616$5.0bn2113
Q2 202613$5.5bn1319

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

IONS and LLY →IONS and JNJ →IONS and VRTX →Choose a stock to compare with IONS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own IONS, latest filings →Back to the 13F Explorer →